Sensorineural hearing loss as a predictor of endothelial dysfunction in some non-communicable diseases in the working population (a review of interdisciplinary studies)

Interdisciplinary publications suggesting an etiopathogenetic relationship between sensorineural hearing loss and some chronic non-communicable diseases were reviewed. A substantial amount of data on atherogenesis, thrombosis and immunological processes affecting the blood circulation of inner ear receptor cells has so far been accumulated. Various reasons for sensorineural hearing loss have been studied, such as changes in the rheological properties of blood; arteriole hypertonicity; precapillar sphincter dysfunction; impaired lipid metabolism leading to the lack of tissue oxygenation and dystrophy and necrosis of the organ of Corti. The definition of endothelial dysfunction has been given. The role of vasomotor, thrombophilic, adhesive and angiogenic forms of endothelial dysfunction in the development and progression of sensorineural hearing loss under the influence of harmful work-related factors, with arterial hypertension, coronary heart disease, diabetes mellitus with the most common and aggressive disorders of the microvasculature has been determined. A clear relationship between the development of sensorineural hearing loss in diabetic microangiopathy has been established. Historical data on the study of the mechanisms of sensorineural hearing loss were analyzed. The aim of this article was to conduct a literature review of interdisciplinary publications with a particular focus on the role of sensorineural hearing loss in the working population in predicting endothelial dysfunction in some chronic non-communicable diseases. The novelty of this article consists in the consideration of occupational and population risk factors for chronic non-communicable diseases in the form of their cascade, which also leads to sensorineural hearing loss.

1. Izmerov N.F., Tikhonova G.I., Gorchakova T.Yu. Mortality of working age population in Russia and indusrial countries in Europe: trends of the last two decades. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2014; 69(7–8): 121–124 (In Russ., English abstract). DOI: 10.15690/vramn.v69i7-8.1118

2. Andreeva G.F., Gorbunov V.M. Main regularities of General seasonal mortality and factors affecting it. Preventive medicine. 2019; 22(5): 143–152. DOI: 10.17116.profmed201922051143

3. Balanova Yu.A., Shal’nova S.A., Deev A.D., Konstantinov V.V., Kapustina A.V. Dynamics of arterial hypertension and its impact on mortality in the Russian population. Sistemnye Gipertenzii. 2014; 11(4): 17–21 (In Russ., English abstract).

4. Izmerov N.F., Piktushanskaya T.E. Mortality parameters of patients with occupational diseases and evaluation of medical care quality. Meditsina Truda i Promyshlennaya Ehkologiya. 2016; (9): 18–23 (In Russ., English abstract).

5. Gilyarevskii S.R. The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects. Sistemnye Gipertenzii. 2014; 11(3): 88–94 (In Russ., English abstract).

6. Parati G., Stergiou G.S., Asmar R., Bilo G., de Leeuw P., Imai Y., et al. Significance of Society of Hypertension practice guidelines for home blood pressure monitoring. J. Hum. Hypertens. 2010; 24(12): 779–785. DOI: 10.1038/jhh.2010.54

7. Artamonova G.V., Maksimov S.A., Ogarkov M.Yu., Makarov S.A., Skripchenko A.E., Indukaeva E.V., et al. Arterial hypertension predictors and occupation. Rossiiskii Kardiologicheskii Zhurnal. 2012; 12(3): 62–67 (In Russ., English abstract).

8. Li J., Loerbroks A., Bosma H., Angerer P. Work stress and cardiovascular disease: A life course perspective. J. Occup. Health. 2016; 58(2): 216–219. DOI: 10.1539/joh.15-0326-OP

9. Babanov S.A., Baraeva R.A. Occupational cardiovascular disease. RMZh. 2015; 23(15): 900–906 (In Russ.).

10. Pankova V.B. The new regulations for diagnostics of occupational hearing impairment. Vestnik Otorinolaringologii. 2014; (2): 44–48 (In Russ., English abstract).

11. Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization; 2015. Available mode: https://apps.who.int/iris/bitstream/handle/10665/44203/9789241563871_eng.pdf?sequence=1&isAllowed=y

12. Vereshchagin A.I., editor. On the state of occupational morbidity in the Russian Federation in 2010. Information collection of statistical and analytical materials. Moscow: Rospotrebnadzor; 2011. 110 р. (In Russ.).

13. Tsfasman A.Z. Profession and hypertension. Moscow: Eksmo; 2013. 192 р. (In Russ.).

14. Tsfasman A.Z. Professional cardiology. Moscow: Reprotsentr; 2007. 208 р. (In Russ.).

15. Mukhin N.A., Kosarev V.V., Babanov S.A., Fomin V.V. Occupational diseases. Moscow: GEOTAR-Media; 2013. 496 р. (In Russ.).

16. Morozova S.V. Sensorineural hearing loss: basic principles of diagnosis and treatment. RMJ . 2001; 15: 662.

17. Glezer M.G. Pulse AD: why is this important? Moscow: Medikom; 2013. 16 р. (In Russ.).

18. Akarachkova E.S., Artemenko A.R., Belyaev A.A., Kadyrova L.R., Kerimova K.S., Kotova O.V., et al. The Brain as a target for stress and arterial hypertension. Medical review. RMJ. 2019; 4 (2): 59–64.

19. Gorbunov V.M. Daily blood pressure monitoring: current aspects. Moscow: Logosfera; 2015. 222 р. (In Russ.).

20. Boitsov S.A., Balanova Yu.A., Shal’nova S.A., Deev A.D., Artamonova G.V., Gatagonova T.M., et al. Arterial hypertension among individuals of 25–64 year sold: prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya Terapiya i Profilaktika. 2014; 13(4): 4–14 (In Russ., English abstract).

21. Syrseloudis D., Tsioufis C., Andrikou I., Mazaraki A., Thomopoulos C., Mihas C., et al. Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertension research: official journal of the Japanese Society of Hypertension. Hypertens. Res. 2011; 34(1): 120–125. DOI: 10.1038/hr.2010.192

22. European guidelines for night noise control. World Health Organization; 2014; Available mode: http://www.euro.who.int/ru/publications/abstracts/night-noise-guidelines-for-europe (In Russ.).

23. Ostroumova O.D. Variability of blood pressure and risk of complications in arterial hypertension. Terapevticheskii Arkhiv. 2012; 84(10): 91–97 (In Russ.).

24. Gorbunov V.M., Smirnova M.I. How to diagnose latent arterial hypertension? Nizhnii Novgorod: Dekom; 2012. 35 р. (In Russ.).

25. Shal’nova S.A., Kontsevaya A.V., Karpov Yu.A., Meshkov A.N., Boitsov S.A. Epidemiological monitoring as a tool for planning programs for the prevention of chronic noncommunicable diseases and their risk factors. Profilakticheskaya Meditsina. 2012; 15(6): 64–68 (In Russ., English abstract).

26. Loewenheim H., Waldhaus J., Hirt B., Sandke S., Müller M. Regenerative medicine in the treatment of sensorineural hearing loss. HNO. 2008; 56(3): 288–300. DOI: 10.1007/s00106-008-1689-y

27. Chernova I.M., Luk’yanov M.M., Serdyuk S.E., Boitsov S.A. Features of risk factors, mechanisms of development, clinical course, and target organ damage in patients with young arterial hypertension. Sistemnye Gipertenzii. 2012; 9(3): 60–65 (In Russ.).

28. Przewozny T., Gojska-Grymajlo A., Kwarciany M., Graff B., Szmuda T., Gasecki D., Narkiewicz K. Hypertension is associated with dysfunction of both peripheral and central auditory system. J. Hypertens. 2016; 34(4): 736–744. DOI: 10.1097/HJH.0000000000000803

29. Zhang X., Weng Y., Xu Y., Xiong H., Liang M., Zheng Y., Ou Y. Selected blood inflammatory and metabolic parameters predicted successive bilateral sudden sensorineural hearing loss. Dis. Markers. 2019; 2019: 7165257. DOI: 10.1155/2019/7165257

30. Canis M., Heigl F., Suckfuell M. Fibrinogen. LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss. Clin. Res. Cardiol. Suppl. 2012; 7: 36–40. DOI: 10.1007/s11789-012-0044-8

31. Kuklina E.V. Dynamics of cochleovestibular disorders in patients with initial manifestations of insufficient blood supply to the brain. Vestnik Otorinolaringologii. 1989; 51(4): 13–16 (In Russ.).

32. Przewozny T., Gojska-Grymajlo A., Kwarciany M., Gasecki D., Narkiewicz K. Hypertension and cochlear hearing loss. Blood Press. 2015; 24(4): 199–205. DOI: 10.3109/08037051.2015.1049466

33. Babisch W., Beule B., Schust M., Kersten N., Ising H. Traffic noise and risk of myocardial infarction. Epidemiology. 2016; 16(1): 33–40. DOI: 10.1097/01.ede.0000147104.84424.24

34. Haremza C., Klopp-Dutote N., Strunski V., Page C. Evaluation of cardiovascular risks and recovery of idiopathic sudden sensorineural hearingloss in hospitalised patients: comparison between complete and partial suddensensorineural hearing loss. J. Laryngol. Otol. 2017; 131(10): 919–924. DOI: 10.1017/S0022215117001736

35. Menezes A.S., Ribeiro D., Lima A., Miranda D., Guimaraes J., Dias L. SCORE risk scale as a prognostic factor after sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology. 2019; 276(10): 2739–2745. DOI: 10.1007/s00405-019-05518-1

36. Graudal N.A., Hubeck-Graudal T., Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am. J. Hypertens. 2012; 25(1): 1–15. DOI: 10.1038/ajh.2011.210

37. Bliziotis I., Destounis A., Stergiou G. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: A systematic review and meta-analysis. J. Hypertens. 2012; 30(7): 1289–1299. DOI: 10.1097/HJH.0b013e3283531eaf

38. Shalygin L.D. Daily rhythms of neurohumoral regulation of hemodynamics in patients with arterial hypertension. Moscow: RAEN; 2012. 190 р. (In Russ.).

39. Alizade I.T. Acoustic dysfunction and microcirculation in patients with diabetes mellitus. Vestnik Otorinolaringologii. 2007; 1: 11–13 (In Russ., English abstract).

40. Koide Y., Teranishi M., Sugiura S., Uchida Y., Nishio N., Kato K., et al. Association between Uncoupling Protein 2 Gene Ala55val Polymorphism and Sudden Sensorineural Hearing Loss. J. Int. Adv. Otol. 2018; 14(2): 166–169. DOI: 10.5152/iao.2018.5442

41. Zirbernagl’ S., Lang F. Clinical pathophysiology. Atlas. Transl. from Engl. Litvitskii P.F., editor. Moscow: Prakticheskaya meditsina; 2019. 448 р. (In Russ.).

42. Mordvinova E.V., Oshchepkova E.V., Fedorovich A.A., Rogoza A.N. The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk. Sistemnye Gipertenzii. 2014; 11(2): 29–35 (In Russ., English abstract).

43. Clark C.E., Taylor R.S., Shore A.C., Ukoumunne O.C., Campbell J.L. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012; 379(9819): 905–914. DOI: 10.1016/S0140-6736(11)61710-8

44. De la Sierra A., Banegas J.R., Segura J., Gorostidi M., Ruilope L.M. Ambulatory blood pressure monitoring and development of cardiovascular events in highrisk patients included in the Spanish ABPM registry: the cardiorisc event study. J. Hypertens. 2012; 30(4): 713–719. DOI: 10.1097/HJH.0b013e328350bb40

45. Floras J.S. Blood pressure variability: a novel and important risk factor. Can. J. Cardiol. 2013; 29(5): 557–563. DOI: 10.1016/j.cjca.2013.02.012